Your browser doesn't support javascript.
loading
Mapping HIV prevalence in Nigeria using small area estimates to develop a targeted HIV intervention strategy.
O'Brien-Carelli, Caitlin; Steuben, Krista; Stafford, Kristen A; Aliogo, Rukevwe; Alagi, Matthias; Johanns, Casey K; Ibrahim, Jahun; Shiraishi, Ray; Ehoche, Akipu; Greby, Stacie; Dirlikov, Emilio; Ibrahim, Dalhatu; Bronson, Megan; Aliyu, Gambo; Aliyu, Sani; Dwyer-Lindgren, Laura; Swaminathan, Mahesh; Duber, Herbert C; Charurat, Man.
Afiliación
  • O'Brien-Carelli C; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, United States of America.
  • Steuben K; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, United States of America.
  • Stafford KA; CIHEB, University of Maryland School of Medicine, Baltimore, MD, United States of America.
  • Aliogo R; Institute of Human Virology, University of Maryland School of Medicine, MD, United States of America.
  • Alagi M; CIHEB, MGIC-An Affiliate of the University of Maryland Baltimore, Abuja, Nigeria.
  • Johanns CK; U.S. Centers for Disease Control and Prevention, Abuja, Nigeria.
  • Ibrahim J; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, United States of America.
  • Shiraishi R; U.S. Centers for Disease Control and Prevention, Abuja, Nigeria.
  • Ehoche A; U.S. Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Greby S; CIHEB, MGIC-An Affiliate of the University of Maryland Baltimore, Abuja, Nigeria.
  • Dirlikov E; U.S. Centers for Disease Control and Prevention, Abuja, Nigeria.
  • Ibrahim D; U.S. Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Bronson M; U.S. Centers for Disease Control and Prevention, Abuja, Nigeria.
  • Aliyu G; U.S. Centers for Disease Control and Prevention, Atlanta, GA, United States of America.
  • Aliyu S; CIHEB, University of Maryland School of Medicine, Baltimore, MD, United States of America.
  • Dwyer-Lindgren L; National Agency for the Control of AIDS, Abuja, Nigeria.
  • Swaminathan M; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, United States of America.
  • Duber HC; U.S. Centers for Disease Control and Prevention, Abuja, Nigeria.
  • Charurat M; Institute for Health Metrics and Evaluation, University of Washington, Seattle, WA, United States of America.
PLoS One ; 17(6): e0268892, 2022.
Article en En | MEDLINE | ID: mdl-35675346
ABSTRACT

OBJECTIVE:

Although geographically specific data can help target HIV prevention and treatment strategies, Nigeria relies on national- and state-level estimates for policymaking and intervention planning. We calculated sub-state estimates along the HIV continuum of care in Nigeria.

DESIGN:

Using data from the Nigeria HIV/AIDS Indicator and Impact Survey (NAIIS) (July-December 2018), we conducted a geospatial analysis estimating three key programmatic indicators prevalence of HIV infection among adults (aged 15-64 years); antiretroviral therapy (ART) coverage among adults living with HIV; and viral load suppression (VLS) rate among adults living with HIV.

METHODS:

We used an ensemble modeling method called stacked generalization to analyze available covariates and a geostatistical model to incorporate the output from stacking as well as spatial autocorrelation in the modeled outcomes. Separate models were fitted for each indicator. Finally, we produced raster estimates of each indicator on an approximately 5×5-km grid and estimates at the sub-state/local government area (LGA) and state level.

RESULTS:

Estimates for all three indicators varied both within and between states. While state-level HIV prevalence ranged from 0.3% (95% uncertainty interval [UI] 0.3%-0.5%]) to 4.3% (95% UI 3.7%-4.9%), LGA prevalence ranged from 0.2% (95% UI 0.1%-0.5%) to 8.5% (95% UI 5.8%-12.2%). Although the range in ART coverage did not substantially differ at state level (25.6%-76.9%) and LGA level (21.9%-81.9%), the mean absolute difference in ART coverage between LGAs within states was 16.7 percentage points (range, 3.5-38.5 percentage points). States with large differences in ART coverage between LGAs also showed large differences in VLS-regardless of level of effective treatment coverage-indicating that state-level geographic targeting may be insufficient to address coverage gaps.

CONCLUSION:

Geospatial analysis across the HIV continuum of care can effectively highlight sub-state variation and identify areas that require further attention in order to achieve epidemic control. By generating local estimates, governments, donors, and other implementing partners will be better positioned to conduct targeted interventions and prioritize resource distribution.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Síndrome de Inmunodeficiencia Adquirida Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Africa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Síndrome de Inmunodeficiencia Adquirida Tipo de estudio: Prevalence_studies / Risk_factors_studies Límite: Adult / Humans País/Región como asunto: Africa Idioma: En Revista: PLoS One Asunto de la revista: CIENCIA / MEDICINA Año: 2022 Tipo del documento: Article País de afiliación: Estados Unidos